<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-10-24" modified="2018-01-31" version="152">
<accession>O95470</accession>
<accession>B2RBD4</accession>
<accession>Q7Z732</accession>
<accession>Q9ULG8</accession>
<accession>Q9UN89</accession>
<name>SGPL1_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="13">Sphingosine-1-phosphate lyase 1</fullName>
<shortName evidence="13">S1PL</shortName>
<shortName evidence="13">SP-lyase 1</shortName>
<shortName evidence="13">SPL 1</shortName>
<shortName>hSPL</shortName>
<ecNumber evidence="6 8 9">4.1.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Sphingosine-1-phosphate aldolase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="14">SGPL1</name>
<name type="synonym" evidence="12">KIAA1252</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Biochim. Biophys. Acta" volume="1487" first="128" last="134">
<title>Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22.</title>
<authorList>
<person name="Van Veldhoven P.P."/>
<person name="Gijsbers S."/>
<person name="Mannaerts G.P."/>
<person name="Vermeesch J.R."/>
<person name="Brys V."/>
</authorList>
<dbReference type="PubMed" id="11018465"/>
<dbReference type="DOI" id="10.1016/S1388-1981(00)00079-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-218 AND CYS-317</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="1281" last="1290">
<title>Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis.</title>
<authorList>
<person name="Reiss U."/>
<person name="Oskouian B."/>
<person name="Zhou J."/>
<person name="Gupta V."/>
<person name="Sooriyakumaran P."/>
<person name="Kelly S."/>
<person name="Wang E."/>
<person name="Merrill A.H. Jr."/>
<person name="Saba J.D."/>
</authorList>
<dbReference type="PubMed" id="14570870"/>
<dbReference type="DOI" id="10.1074/jbc.M309646200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-353</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="DNA Res." volume="6" first="337" last="345">
<title>Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Kikuno R."/>
<person name="Hirosawa M."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="10574462"/>
<dbReference type="DOI" id="10.1093/dnares/6.5.337"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Anal. Biochem." volume="354" first="279" last="289">
<title>Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry.</title>
<authorList>
<person name="Zhan X."/>
<person name="Desiderio D.M."/>
</authorList>
<dbReference type="PubMed" id="16777052"/>
<dbReference type="DOI" id="10.1016/j.ab.2006.05.024"/>
</citation>
<scope>NITRATION [LARGE SCALE ANALYSIS] AT TYR-356 AND TYR-366</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Pituitary adenoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-564</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-353</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2014" name="J. Med. Chem." volume="57" first="5074" last="5084">
<title>Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.</title>
<authorList>
<person name="Weiler S."/>
<person name="Braendlin N."/>
<person name="Beerli C."/>
<person name="Bergsdorf C."/>
<person name="Schubart A."/>
<person name="Srinivas H."/>
<person name="Oberhauser B."/>
<person name="Billich A."/>
</authorList>
<dbReference type="PubMed" id="24809814"/>
<dbReference type="DOI" id="10.1021/jm500338n"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 62-568 IN COMPLEX WITH PYRIDOXAL PHOSPHATE AND SYNTHETIC INHIBITOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>FUNCTION</scope>
<scope>COFACTOR</scope>
<scope>SUBUNIT</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="365" last="372">
<title>Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications.</title>
<authorList>
<person name="Janecke A.R."/>
<person name="Xu R."/>
<person name="Steichen-Gersdorf E."/>
<person name="Waldegger S."/>
<person name="Entenmann A."/>
<person name="Giner T."/>
<person name="Krainer I."/>
<person name="Huber L.A."/>
<person name="Hess M.W."/>
<person name="Frishberg Y."/>
<person name="Barash H."/>
<person name="Tzur S."/>
<person name="Schreyer-Shafir N."/>
<person name="Sukenik-Halevy R."/>
<person name="Zehavi T."/>
<person name="Raas-Rothschild A."/>
<person name="Mao C."/>
<person name="Mueller T."/>
</authorList>
<dbReference type="PubMed" id="28181337"/>
<dbReference type="DOI" id="10.1002/humu.23192"/>
</citation>
<scope>INVOLVEMENT IN NPHS14</scope>
<scope>VARIANT NPHS14 505-ARG--HIS-568 DEL</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2017" name="J. Clin. Invest." volume="127" first="912" last="928">
<title>Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency.</title>
<authorList>
<person name="Lovric S."/>
<person name="Goncalves S."/>
<person name="Gee H.Y."/>
<person name="Oskouian B."/>
<person name="Srinivas H."/>
<person name="Choi W.I."/>
<person name="Shril S."/>
<person name="Ashraf S."/>
<person name="Tan W."/>
<person name="Rao J."/>
<person name="Airik M."/>
<person name="Schapiro D."/>
<person name="Braun D.A."/>
<person name="Sadowski C.E."/>
<person name="Widmeier E."/>
<person name="Jobst-Schwan T."/>
<person name="Schmidt J.M."/>
<person name="Girik V."/>
<person name="Capitani G."/>
<person name="Suh J.H."/>
<person name="Lachaussee N."/>
<person name="Arrondel C."/>
<person name="Patat J."/>
<person name="Gribouval O."/>
<person name="Furlano M."/>
<person name="Boyer O."/>
<person name="Schmitt A."/>
<person name="Vuiblet V."/>
<person name="Hashmi S."/>
<person name="Wilcken R."/>
<person name="Bernier F.P."/>
<person name="Innes A.M."/>
<person name="Parboosingh J.S."/>
<person name="Lamont R.E."/>
<person name="Midgley J.P."/>
<person name="Wright N."/>
<person name="Majewski J."/>
<person name="Zenker M."/>
<person name="Schaefer F."/>
<person name="Kuss N."/>
<person name="Greil J."/>
<person name="Giese T."/>
<person name="Schwarz K."/>
<person name="Catheline V."/>
<person name="Schanze D."/>
<person name="Franke I."/>
<person name="Sznajer Y."/>
<person name="Truant A.S."/>
<person name="Adams B."/>
<person name="Desir J."/>
<person name="Biemann R."/>
<person name="Pei Y."/>
<person name="Ars E."/>
<person name="Lloberas N."/>
<person name="Madrid A."/>
<person name="Dharnidharka V.R."/>
<person name="Connolly A.M."/>
<person name="Willing M.C."/>
<person name="Cooper M.A."/>
<person name="Lifton R.P."/>
<person name="Simons M."/>
<person name="Riezman H."/>
<person name="Antignac C."/>
<person name="Saba J.D."/>
<person name="Hildebrandt F."/>
</authorList>
<dbReference type="PubMed" id="28165339"/>
<dbReference type="DOI" id="10.1172/JCI89626"/>
</citation>
<scope>INVOLVEMENT IN NPHS14</scope>
<scope>VARIANTS NPHS14 GLN-222; TRP-222; ILE-346 AND CYS-416</scope>
<scope>CHARACTERIZATION OF VARIANTS NPHS14 GLN-222 AND ILE-346</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PATHWAY</scope>
<scope>MUTAGENESIS OF GLU-132</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2017" name="J. Clin. Invest." volume="127" first="942" last="953">
<title>Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome.</title>
<authorList>
<person name="Prasad R."/>
<person name="Hadjidemetriou I."/>
<person name="Maharaj A."/>
<person name="Meimaridou E."/>
<person name="Buonocore F."/>
<person name="Saleem M."/>
<person name="Hurcombe J."/>
<person name="Bierzynska A."/>
<person name="Barbagelata E."/>
<person name="Bergada I."/>
<person name="Cassinelli H."/>
<person name="Das U."/>
<person name="Krone R."/>
<person name="Hacihamdioglu B."/>
<person name="Sari E."/>
<person name="Yesilkaya E."/>
<person name="Storr H.L."/>
<person name="Clemente M."/>
<person name="Fernandez-Cancio M."/>
<person name="Camats N."/>
<person name="Ram N."/>
<person name="Achermann J.C."/>
<person name="Van Veldhoven P.P."/>
<person name="Guasti L."/>
<person name="Braslavsky D."/>
<person name="Guran T."/>
<person name="Metherell L.A."/>
</authorList>
<dbReference type="PubMed" id="28165343"/>
<dbReference type="DOI" id="10.1172/JCI90171"/>
</citation>
<scope>INVOLVEMENT IN NPHS14</scope>
<scope>VARIANTS NPHS14 GLN-222 AND PHE-545 DEL</scope>
<scope>CHARACTERIZATION OF VARIANTS NPHS14 GLN-222 AND PHE-545 DEL</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<comment type="function">
<text evidence="6 7 8 9">Cleaves phosphorylated sphingoid bases (PSBs), such as sphingosine-1-phosphate, into fatty aldehydes and phosphoethanolamine. Elevates stress-induced ceramide production and apoptosis.</text>
</comment>
<comment type="catalytic activity">
<text evidence="6 8 9">Sphinganine 1-phosphate = phosphoethanolamine + palmitaldehyde.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="8">
<name>pyridoxal 5'-phosphate</name>
<dbReference type="ChEBI" id="CHEBI:597326"/>
</cofactor>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="8">5.2 uM for sphingosine 1-phosphate</KM>
</kinetics>
</comment>
<comment type="pathway" evidence="6 8 9">
<text>Lipid metabolism; sphingolipid metabolism.</text>
</comment>
<comment type="subunit">
<text evidence="8">Homodimer.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1046170"/>
<interactant intactId="EBI-2800345">
<id>Q86WV6</id>
<label>TMEM173</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="7">Endoplasmic reticulum membrane</location>
<topology evidence="5">Single-pass type III membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="6 10">Ubiquitously expressed (PubMed:11018465, PubMed:28165343). Expressed in fetal and adult adrenal gland (at protein level) (PubMed:28165343).</text>
</comment>
<comment type="disease" evidence="9 10 11">
<disease id="DI-05043">
<name>Nephrotic syndrome 14</name>
<acronym>NPHS14</acronym>
<description>A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. NPHS14 is an autosomal recessive syndromic, steroid-resistant form that progresses to end-stage renal failure. Some NPHS14 patients manifest ichthyosis, adrenal insufficiency, immunodeficiency, and neurological defects.</description>
<dbReference type="MIM" id="617575"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="13">Belongs to the group II decarboxylase family. Sphingosine-1-phosphate lyase subfamily.</text>
</comment>
<comment type="sequence caution" evidence="13">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA86566" version="1"/>
</conflict>
</comment>
<dbReference type="EC" id="4.1.2.27" evidence="6 8 9"/>
<dbReference type="EMBL" id="AJ011304">
<property type="protein sequence ID" value="CAA09590.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF144638">
<property type="protein sequence ID" value="AAD44755.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB033078">
<property type="protein sequence ID" value="BAA86566.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314615">
<property type="protein sequence ID" value="BAG37181.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471083">
<property type="protein sequence ID" value="EAW54414.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC052991">
<property type="protein sequence ID" value="AAH52991.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31216.1"/>
<dbReference type="RefSeq" id="NP_003892.2">
<property type="nucleotide sequence ID" value="NM_003901.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005270320.1">
<property type="nucleotide sequence ID" value="XM_005270263.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011538618.1">
<property type="nucleotide sequence ID" value="XM_011540316.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011538619.1">
<property type="nucleotide sequence ID" value="XM_011540317.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.499984"/>
<dbReference type="PDB" id="4Q6R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=62-568"/>
</dbReference>
<dbReference type="PDBsum" id="4Q6R"/>
<dbReference type="ProteinModelPortal" id="O95470"/>
<dbReference type="SMR" id="O95470"/>
<dbReference type="BioGrid" id="114398">
<property type="interactions" value="53"/>
</dbReference>
<dbReference type="IntAct" id="O95470">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000362298"/>
<dbReference type="BindingDB" id="O95470"/>
<dbReference type="ChEMBL" id="CHEMBL3286061"/>
<dbReference type="DrugBank" id="DB00114">
<property type="generic name" value="Pyridoxal Phosphate"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2522"/>
<dbReference type="SwissLipids" id="SLP:000000107"/>
<dbReference type="iPTMnet" id="O95470"/>
<dbReference type="PhosphoSitePlus" id="O95470"/>
<dbReference type="SwissPalm" id="O95470"/>
<dbReference type="BioMuta" id="SGPL1"/>
<dbReference type="EPD" id="O95470"/>
<dbReference type="MaxQB" id="O95470"/>
<dbReference type="PaxDb" id="O95470"/>
<dbReference type="PeptideAtlas" id="O95470"/>
<dbReference type="PRIDE" id="O95470"/>
<dbReference type="Ensembl" id="ENST00000373202">
<property type="protein sequence ID" value="ENSP00000362298"/>
<property type="gene ID" value="ENSG00000166224"/>
</dbReference>
<dbReference type="GeneID" id="8879"/>
<dbReference type="KEGG" id="hsa:8879"/>
<dbReference type="UCSC" id="uc001jrm.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8879"/>
<dbReference type="DisGeNET" id="8879"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000166224.16"/>
<dbReference type="GeneCards" id="SGPL1"/>
<dbReference type="HGNC" id="HGNC:10817">
<property type="gene designation" value="SGPL1"/>
</dbReference>
<dbReference type="HPA" id="HPA021125"/>
<dbReference type="HPA" id="HPA023086"/>
<dbReference type="MIM" id="603729">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617575">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O95470"/>
<dbReference type="OpenTargets" id="ENSG00000166224"/>
<dbReference type="PharmGKB" id="PA35725"/>
<dbReference type="eggNOG" id="KOG1383">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0076">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000000046"/>
<dbReference type="HOGENOM" id="HOG000190693"/>
<dbReference type="HOVERGEN" id="HBG056982"/>
<dbReference type="InParanoid" id="O95470"/>
<dbReference type="KO" id="K01634"/>
<dbReference type="OMA" id="DSCGCVT"/>
<dbReference type="OrthoDB" id="EOG091G040L"/>
<dbReference type="PhylomeDB" id="O95470"/>
<dbReference type="TreeFam" id="TF300777"/>
<dbReference type="BRENDA" id="4.1.2.27">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660661">
<property type="pathway name" value="Sphingolipid de novo biosynthesis"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00222"/>
<dbReference type="ChiTaRS" id="SGPL1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SGPL1"/>
<dbReference type="GenomeRNAi" id="8879"/>
<dbReference type="PRO" id="PR:O95470"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000166224"/>
<dbReference type="CleanEx" id="HS_SGPL1"/>
<dbReference type="ExpressionAtlas" id="O95470">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O95470">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030176">
<property type="term" value="C:integral component of endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016831">
<property type="term" value="F:carboxy-lyase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0030170">
<property type="term" value="F:pyridoxal phosphate binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0008117">
<property type="term" value="F:sphinganine-1-phosphate aldolase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008209">
<property type="term" value="P:androgen metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097190">
<property type="term" value="P:apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006672">
<property type="term" value="P:ceramide metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008210">
<property type="term" value="P:estrogen metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060325">
<property type="term" value="P:face morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006631">
<property type="term" value="P:fatty acid metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010761">
<property type="term" value="P:fibroblast migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030097">
<property type="term" value="P:hemopoiesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001822">
<property type="term" value="P:kidney development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033327">
<property type="term" value="P:Leydig cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001553">
<property type="term" value="P:luteinization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060021">
<property type="term" value="P:palate development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048008">
<property type="term" value="P:platelet-derived growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009791">
<property type="term" value="P:post-embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0040014">
<property type="term" value="P:regulation of multicellular organism growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048705">
<property type="term" value="P:skeletal system morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030148">
<property type="term" value="P:sphingolipid biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030149">
<property type="term" value="P:sphingolipid catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001570">
<property type="term" value="P:vasculogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.640.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.1150.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR002129">
<property type="entry name" value="PyrdxlP-dep_de-COase"/>
</dbReference>
<dbReference type="InterPro" id="IPR015424">
<property type="entry name" value="PyrdxlP-dep_Trfase"/>
</dbReference>
<dbReference type="InterPro" id="IPR015421">
<property type="entry name" value="PyrdxlP-dep_Trfase_major_sub1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015422">
<property type="entry name" value="PyrdxlP-dep_Trfase_sub2"/>
</dbReference>
<dbReference type="Pfam" id="PF00282">
<property type="entry name" value="Pyridoxal_deC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF53383">
<property type="entry name" value="SSF53383"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0456">Lyase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0944">Nitration</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0663">Pyridoxal phosphate</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0746">Sphingolipid metabolism</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="chain" description="Sphingosine-1-phosphate lyase 1" id="PRO_0000147012">
<location>
<begin position="1"/>
<end position="568"/>
</location>
</feature>
<feature type="topological domain" description="Lumenal" evidence="5">
<location>
<begin position="1"/>
<end position="40"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type III membrane protein" evidence="5">
<location>
<begin position="41"/>
<end position="61"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="5">
<location>
<begin position="62"/>
<end position="568"/>
</location>
</feature>
<feature type="modified residue" description="N6-(pyridoxal phosphate)lysine; alternate">
<location>
<position position="353"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="3">
<location>
<position position="353"/>
</location>
</feature>
<feature type="modified residue" description="Nitrated tyrosine" evidence="2">
<location>
<position position="356"/>
</location>
</feature>
<feature type="modified residue" description="Nitrated tyrosine" evidence="2">
<location>
<position position="366"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="564"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12770335." id="VAR_048875">
<original>V</original>
<variation>L</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="sequence variant" description="In NPHS14; decreased protein abundance; increased aggregation; decreased sphinganine-1-phosphate aldolase activity; dbSNP:rs769259446." id="VAR_079213" evidence="9 10">
<original>R</original>
<variation>Q</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In NPHS14." id="VAR_079214" evidence="9">
<original>R</original>
<variation>W</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In NPHS1; decreased protein abundance in cells of patients homozygous for the mutation; increased aggregation; decreased sphinganine-1-phosphate aldolase activity." id="VAR_079215" evidence="9">
<original>S</original>
<variation>I</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="sequence variant" description="In NPHS14; unknown pathological significance; dbSNP:rs779485098." id="VAR_079216" evidence="9">
<original>Y</original>
<variation>C</variation>
<location>
<position position="416"/>
</location>
</feature>
<feature type="sequence variant" description="In NPHS14." id="VAR_079217" evidence="11">
<location>
<begin position="505"/>
<end position="568"/>
</location>
</feature>
<feature type="sequence variant" description="In NPHS14; decreased protein abundance." id="VAR_079218" evidence="10">
<location>
<position position="545"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the sphinganine-1-phosphate aldolase activity; no effect on protein abundance." evidence="9">
<original>E</original>
<variation>G</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of sphinganine-1-phosphate aldolase activity." evidence="6">
<original>C</original>
<variation>G</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost no sphinganine-1-phosphate aldolase activity." evidence="6">
<original>C</original>
<variation>S</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of sphinganine-1-phosphate aldolase activity." evidence="7">
<original>K</original>
<variation>L</variation>
<location>
<position position="353"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA09590." ref="1" evidence="13">
<original>C</original>
<variation>A</variation>
<location>
<position position="404"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="123"/>
<end position="134"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="135"/>
<end position="137"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="139"/>
<end position="142"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="145"/>
<end position="148"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="154"/>
<end position="165"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="166"/>
<end position="169"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="175"/>
<end position="177"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="179"/>
<end position="195"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="203"/>
<end position="209"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="210"/>
<end position="227"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="234"/>
<end position="238"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="244"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="255"/>
<end position="259"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="265"/>
<end position="267"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="269"/>
<end position="273"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="280"/>
<end position="286"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="290"/>
<end position="292"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="298"/>
<end position="308"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="312"/>
<end position="316"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="317"/>
<end position="319"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="320"/>
<end position="323"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="324"/>
<end position="330"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="344"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="362"/>
<end position="368"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="369"/>
<end position="372"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="373"/>
<end position="375"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="377"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="387"/>
<end position="392"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="398"/>
<end position="434"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="448"/>
<end position="454"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="456"/>
<end position="458"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="461"/>
<end position="469"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="475"/>
<end position="477"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="478"/>
<end position="481"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="482"/>
<end position="486"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="489"/>
<end position="494"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="497"/>
<end position="513"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="521"/>
<end position="531"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="535"/>
<end position="549"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4Q6R"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16777052"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11018465"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14570870"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24809814"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28165339"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28165343"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28181337"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10574462"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000305"/>
<evidence key="14" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:10817"/>
</source>
</evidence>
<sequence length="568" mass="63524" checksum="3B16FDEFC4B2FDB6" modified="2003-10-24" version="3">
MPSTDLLMLKAFEPYLEILEVYSTKAKNYVNGHCTKYEPWQLIAWSVVWTLLIVWGYEFV
FQPESLWSRFKKKCFKLTRKMPIIGRKIQDKLNKTKDDISKNMSFLKVDKEYVKALPSQG
LSSSAVLEKLKEYSSMDAFWQEGRASGTVYSGEEKLTELLVKAYGDFAWSNPLHPDIFPG
LRKIEAEIVRIACSLFNGGPDSCGCVTSGGTESILMACKAYRDLAFEKGIKTPEIVAPQS
AHAAFNKAASYFGMKIVRVPLTKMMEVDVRAMRRAISRNTAMLVCSTPQFPHGVIDPVPE
VAKLAVKYKIPLHVDACLGGFLIVFMEKAGYPLEHPFDFRVKGVTSISADTHKYGYAPKG
SSLVLYSDKKYRNYQFFVDTDWQGGIYASPTIAGSRPGGISAACWAALMHFGENGYVEAT
KQIIKTARFLKSELENIKGIFVFGNPQLSVIALGSRDFDIYRLSNLMTAKGWNLNQLQFP
PSIHFCITLLHARKRVAIQFLKDIRESVTQIMKNPKAKTTGMGAIYGMAQTTVDRNMVAE
LSSVFLDSLYSTDTVTQGSQMNGSPKPH
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>